Abiopharma

Replace - Annual General Meeting :: Voluntary

ASE Holdings Hosts Annual Supplier Day to Recognize Outstanding Suppliers of 2025

General Announcement: CHANGES IN SUBSTANTIAL SHAREHOLDERS INTEREST PURSUANT TO SECTION 138 OF THE COMPANIES ACT 2016

New Form POS AM - Senti Biosciences, Inc. <b>Filed:</b> 2026-04-24 <b>AccNo:</b> 0001193125-26-175244 <b>Size:</b> 20 KB

General Announcement: MINUTES OF EXTRAORDINARY GENERAL MEETING HELD ON 16 APRIL 2026

Financial Statements and Related Announcement: Notification of Results Release

General Announcement: Composition of the Board and Board Committees

Change - Announcement of Appointment: Appointment of Independent Director

Annual Reports and Related Documents:

General Announcement: Approval by High Court of the Deferred Prosecution Agreement with Singapore Authorities

Change - Announcement of Cessation: Cessation of Alternate Director

Disclosure of Interest/ Changes in Interest of Substantial Shareholder(s)/ Unitholder(s): Disclosure of Interest/Change in Interest of Substantial Shareholder(s)/Unitholder(s)

Change - Announcement of Cessation: Retirement of Non-Executive and Non-Independent Director

Annual Reports and Related Documents:

Change - Announcement of Cessation: Retirement of Independent Director